These findings revealed the significance of ACLY in modulating EC metabolism and proinflammatory activation in sepsis, implying the great therapeutic potential of ACLY for treating EC dysfunction-associated tissue injuries in sepsis. The gene discussed is ACLY; the disease is Sepsis.